Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular profiling of patient-derived breast cancer xenografts.
Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, De Plater L, Gentien D, Poupon MF, Cottu P, De Cremoux P, Gestraud P, Vincent-Salomon A, Fontaine JJ, Roman-Roman S, Delattre O, Decaudin D, Marangoni E. Reyal F, et al. Breast Cancer Res. 2012 Jan 16;14(1):R11. doi: 10.1186/bcr3095. Breast Cancer Res. 2012. PMID: 22247967 Free PMC article.
No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer.
Rozan S, Vincent-Salomon A, Zafrani B, Validire P, De Cremoux P, Bernoux A, Nieruchalski M, Fourquet A, Clough K, Dieras V, Pouillart P, Sastre-Garau X. Rozan S, et al. Int J Cancer. 1998 Feb 20;79(1):27-33. doi: 10.1002/(sici)1097-0215(19980220)79:1<27::aid-ijc6>3.0.co;2-y. Int J Cancer. 1998. PMID: 9495354 Free article.
Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsies.
de Cremoux P, Martin EC, Vincent-Salomon A, Dieras V, Barbaroux C, Liva S, Pouillart P, Sastre-Garau X, Magdelenat H. de Cremoux P, et al. Int J Cancer. 1999 Oct 8;83(2):157-61. doi: 10.1002/(sici)1097-0215(19991008)83:2<157::aid-ijc2>3.0.co;2-l. Int J Cancer. 1999. PMID: 10471520 Free article. Clinical Trial.
ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy.
Vincent-Salomon A, Carton M, Freneaux P, Palangie T, Beuzeboc P, Mouret E, de Crémoux P, Coué O, Zafrani B, Nicolas A, Clough K, Fourquet A, Pouillart P, Sastre-Garau X. Vincent-Salomon A, et al. Eur J Cancer. 2000 Mar;36(5):586-91. doi: 10.1016/s0959-8049(99)00339-1. Eur J Cancer. 2000. PMID: 10738122
High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases.
Zafrani B, Aubriot MH, Mouret E, De Crémoux P, De Rycke Y, Nicolas A, Boudou E, Vincent-Salomon A, Magdelénat H, Sastre-Garau X. Zafrani B, et al. Histopathology. 2000 Dec;37(6):536-45. doi: 10.1046/j.1365-2559.2000.01006.x. Histopathology. 2000. PMID: 11122436
Medullary breast carcinoma: prognostic implications of p53 expression.
Dendale R, Vincent-Salomon A, Mouret-Fourme E, Savignoni A, Medioni J, Campana F, Vilcoq JR, de la Rochefordière A, Soussi T, Asselain B, de Cremoux P, Fourquet A. Dendale R, et al. Int J Biol Markers. 2003 Apr-Jun;18(2):99-105. doi: 10.5301/jbm.2008.1279. Int J Biol Markers. 2003. PMID: 12841678 Free article.
431 results